KPTI — Karyopharm Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Karyopharm Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	249	229	278	191	109
Net Total Accounts Receivable
Net Total Receivables	12.9	22.5	47.1	27	30.8
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	277	276	350	234	156
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	11.6	9.56	7.38	4.88	6.28
Long Term Investments
Other Long Term Assets
Total Assets	313	305	358	240	164
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	60.2	73.7	65.9	69.5	92.3
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	263	385	375	377	350
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	50.5	-79.7	-16.7	-136	-186
Total Liabilities & Shareholders' Equity	313	305	358	240	164
Total Common Shares Outstanding